Melissa Schwartz, Komal Luthra, Sophia Salingaros, Ahmed Khawer, Paulina Giacomelli, Ryan Roemmich, Pranamya Suri, Scott Benkovic, Akhil Chhatre
{"title":"Patient reported outcomes following genicular nerve radio frequency ablation for osteoarthritis-related knee pain.","authors":"Melissa Schwartz, Komal Luthra, Sophia Salingaros, Ahmed Khawer, Paulina Giacomelli, Ryan Roemmich, Pranamya Suri, Scott Benkovic, Akhil Chhatre","doi":"10.1080/17581869.2025.2567833","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Genicular radiofrequency ablation (RFA) is a minimally invasive treatment for knee pain with variable outcomes reported. This study aimed to evaluate genicular RFA in reducing pain and identify predictors of treatment success.</p><p><strong>Methods: </strong> This retrospective study included 34 patients who underwent genicular RFA between April 2022 and December 2023. Data on demographics, pre- and post-procedure pain levels, and clinical variables were collected through chart reviews and follow-up surveys. The primary outcome was pain reduction at postoperative follow up. Statistical analyses were conducted to identify predictors of pain outcomes.</p><p><strong>Results: </strong>RFA led to pain reduction in 24 patients (71%), though only 9 (26%) achieved >50% relief according to IMMPACT criteria. The mean pre-procedure pain score was 7.1 ± 1.4, which decreased to 5.2 ± 2.0 post-procedure. Lower pre-procedure Numeric Rating Score (NRS) was the strongest predictor of success (P < 0.001), while age, BMI, gender, and arthritis severity did not significantly impact outcomes.</p><p><strong>Conclusion: </strong>While genicular RFA led to pain reduction in a majority of patients, only a subset experienced clinically significant improvement. Pre-procedure pain score was a key predictor of outcomes, suggesting the need for more refined patient selection criteria and further research into optimizing treatment targets.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":" ","pages":"1-6"},"PeriodicalIF":1.5000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17581869.2025.2567833","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Genicular radiofrequency ablation (RFA) is a minimally invasive treatment for knee pain with variable outcomes reported. This study aimed to evaluate genicular RFA in reducing pain and identify predictors of treatment success.
Methods: This retrospective study included 34 patients who underwent genicular RFA between April 2022 and December 2023. Data on demographics, pre- and post-procedure pain levels, and clinical variables were collected through chart reviews and follow-up surveys. The primary outcome was pain reduction at postoperative follow up. Statistical analyses were conducted to identify predictors of pain outcomes.
Results: RFA led to pain reduction in 24 patients (71%), though only 9 (26%) achieved >50% relief according to IMMPACT criteria. The mean pre-procedure pain score was 7.1 ± 1.4, which decreased to 5.2 ± 2.0 post-procedure. Lower pre-procedure Numeric Rating Score (NRS) was the strongest predictor of success (P < 0.001), while age, BMI, gender, and arthritis severity did not significantly impact outcomes.
Conclusion: While genicular RFA led to pain reduction in a majority of patients, only a subset experienced clinically significant improvement. Pre-procedure pain score was a key predictor of outcomes, suggesting the need for more refined patient selection criteria and further research into optimizing treatment targets.